Nearly 10 million adults found to be severely nearsighted in the United States

June 21, 2016

SAN FRANCISCO - June 21, 2016 - A new study estimates that 9.6 million adults in the United States are highly myopic, or severely nearsighted. Of those, nearly 820,000 have a degenerative form of the disease and more than 41,000 suffer a complication called myopic choroidal neovascularization that could cause long-term vision loss, with women at higher risk. The findings are being published online today in Ophthalmology, the journal of the American Academy of Ophthalmology. This is the first large-scale study ever done to calculate the real-world prevalence of myopic choroidal neovascularization in the United States.

Myopia has become increasingly common over the past several decades. In the United States, the number of nearsighted people rose from about 25 percent in the early 1970s to 40 percent around the turn of millennium. While nearsightedness often can be corrected with eyewear or surgery, severe nearsightedness in which the eye continues to elongate can result in complications as the eye stretches.

Progressive high myopia, also called pathologic myopia, is a degenerative form of the disease. It can cause atrophy of the retina that lines the back of the eye. People with high myopia and the degenerative form are at higher risk of myopic choroidal neovascularization. This condition is characterized by the growth of new, unstable blood vessels beneath the retina. If untreated, it can cause vision loss that may then become permanent. As the prevalence of myopia continues rising, researchers are looking to better understand myopic choroidal neovascularization.

This study was conducted jointly by investigators from the American Academy of Ophthalmology, Genentech, the National Institutes of Health and UC Davis. Among the findings: "Prior to this study, we really had no idea how many people had myopic choroidal neovascularization, which can be devastating," said lead author Jeffrey Willis, M.D., Ph.D., a retina fellow at the UC Davis Eye Center and a clinical research fellow at Genentech. "I think the findings emphasize the growing issue of nearsightedness and the burden it creates in terms of medical complications that cannot be fixed with just glasses or contacts."

To calculate the prevalence of high myopia, the team took diagnosis data from 8,865 participants in the National Health and Nutrition Examination Survey (NHANES) from 2005 through 2008. They applied the prevalence to 2014 U.S. Census Bureau population numbers to estimate the number of people affected. On its own, NHANES does not have a large enough sample size or the right type of ophthalmic data to accurately calculate the prevalence of myopic choroidal neovascularization. To do that, and to find the prevalence of progressive high myopia, researchers turned to 2014 data on 2.6 million individuals in the Academy's IRIS Registry®, the nation's only comprehensive database of ophthalmic patient outcomes. The rate was then applied to the high myopia population numbers to come up with real-world estimates.

The IRIS Registry is the only source of real-time data on ophthalmic care nationwide. It currently holds clinical information from 88 million office visits to 13,739 ophthalmologists and eye care professionals. Without this volume of clinical information, the prevalence of these diseases among a real-world population could not have been calculated, researchers said.

"The sheer size of the IRIS Registry gives us tremendous research capabilities we did not possess before in ophthalmology," said retina specialist David W. Parke, II, M.D., CEO of the American Academy of Ophthalmology and a co-author of the study. "We believe using IRIS Registry data to more accurately establish eye disease prevalence, find new risk factors and evaluate treatments for many types of eye conditions will become more common, to the benefit of the public."
"The Prevalence of Myopic Choroidal Neovascularization in the United States," Willis et al. Ophthalmology, article in press, June 2016. DOI: 10.1016/j.ophtha.2016.04.021. For a full copy of the study or more information, please contact the Academy's Public Relations Department at

For more information on myopia or other eye conditions and diseases, visit the American Academy of Ophthalmology's EyeSmart® website.

About the American Academy of Ophthalmology

The American Academy of Ophthalmology is the world's largest membership association of eye physicians and surgeons. A global community of 32,000 ophthalmologists, we are passionate about protecting sight and fighting preventable blindness. For more than 120 years, we have been educators, innovators and advocates for the public and our profession to ensure the highest-quality medical and surgical eye care. Our EyeSmart® program is a preeminent source of eye health information for the public and empowers people to preserve their vision. For more information, visit

About Ophthalmology

Ophthalmology, the official journal of the American Academy of Ophthalmology, publishes original, peer-reviewed, clinically-applicable research. Topics include the results of clinical trials, new diagnostic and surgical techniques, treatment methods, technology assessments, translational science reviews and editorials. For more information, visit

American Academy of Ophthalmology

Related Myopia Articles from Brightsurf:

Six-Year MiSight contact lens study: 23% of eyes showed no additional myopia progression
The latest findings from the long-running CooperVision MiSight 1 day clinical study provide new insights about myopia management and the proven efficacy of the specially designed contact lens.

Multifocal contact lenses slow myopia progression in children
Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.

Young nearsighted kids benefit from bifocal contact lenses, study shows
Bifocal contact lenses aren't just for aging eyes anymore. In nearsighted kids as young as 7 years old, multifocal contact lenses with a heavy dose of added reading power can dramatically slow further progression of myopia, new research has found.

New paper helps advance myopia management strategies
'Myopia Control 2020: Where are we and where are we heading?' has been published in Ophthalmic & Physiological Optics, the peer-reviewed journal of The College of Optometrists, giving eye care practitioners a comprehensive analysis of evidence-based information needed to help manage myopia.

Genetic processes that determine short-sightedness discovered by researchers
Three previously unknown genetic mechanisms have been discovered in causing myopia otherwise known as short or near-sightedness, finds a new study.

Faster, cheaper tests for myopia possible
The world's most common vision problem myopia or short/near sightedness, which causes damage to the eye and even blindness, just got easier to assess.

New approach to slowing nearsightedness in children shows promise
Combining 2 different treatment methods to slow the progression of myopia may deliver better results than either can achieve on their own.

Bright lights outdoors may help treat lazy eye in children
Amblyopia, also known as lazy eye, is a loss of vision that affects two to five percent of children across the world and originates from a deficit in visual cortical circuitry.

US $244 billion lost annually because people don't have spectacles to correct myopia
Vision impairment caused by uncorrected myopia cost the global economy an estimated US$244 billion in lost productivity in 2015, according to a new study published in the scientific journal Ophthalmology.

Study shows how light therapy might help premature babies avoid vision problems
Scientists discovered a light-dependent molecular pathway that regulates how blood vessels develop in the eye.

Read More: Myopia News and Myopia Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to